AMD Recommends Rejection of “Mini-Tender” Offer from
SANTA CLARA, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) was notified on March 27, 2024 of an unsolicited "mini-tender"...
OPTX) Secures New Optics Order for
ROCHESTER, NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- Syntec Optics (Nasdaq: OPTX), a mission-critical supplier of scientific and technical instruments and...
Movella Files Form 25 to Voluntarily Delist its Securities
HENDERSON, Nev., April 01, 2024 (GLOBE NEWSWIRE) -- Movella Holdings Inc. (NASDAQ: MVLA) (“Movella” or the “Company”), a leading full-stack provider of...
Osisko Metals Grants Stock Options
MONTREAL, March 27, 2024 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the "Company" or "Osisko Metals") (TSX-V: OM; OTCQX: OMZNF; FRANKFURT: 0B51) wishes...
Five Star Bancorp Announces Pricing of Common Stock
RANCHO CORDOVA, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- (March 28, 2024) – Five Star Bancorp (Nasdaq: FSBC) (“Five Star” or the...
KraneShares China Internet & Covered Call ETF (Ticker:
NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- KraneShares, a leading global ETF provider specializing in China, climate, and uncorrelated assets, today...
Pyxis Oncology Reports Inducement Grants Under Nasdaq
BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics...
Verve Therapeutics Announces Inducement Grants under Nasdaq
BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular...
Pending Home Sales Rose 1.6% in February
WASHINGTON, March 28, 2024 (GLOBE NEWSWIRE) -- Key Highlights Pending home sales increased 1.6% in February.Month over...
NextGen Digital Platforms Inc. Closes Oversubscribed
THIS NEWS RELEASE IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES ...
Dyne Therapeutics Reports Inducement Grant Under Nasdaq
WALTHAM, Mass., March 27, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative...
Class 1 Nickel Announces Option Grant
TORONTO, March 27, 2024 (GLOBE NEWSWIRE) -- Class 1 Nickel and Technologies Limited (CSE: NICO/ OTCQB: NICLF) (the “Company” or “Class 1...
